洛米他匹德在英国的三年治疗经验

{"title":"洛米他匹德在英国的三年治疗经验","authors":"J. Cegla, S. Walji, C. Neuwirth, L. Barton, G. Thompson, J. Scott","doi":"10.1016/j.atherosclerosissup.2019.08.014","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8592,"journal":{"name":"Atherosclerosis. Supplements","volume":"38 ","pages":"Pages e6-e7"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.atherosclerosissup.2019.08.014","citationCount":"0","resultStr":"{\"title\":\"Three years experience of lomitapide therapy in the uk\",\"authors\":\"J. Cegla, S. Walji, C. Neuwirth, L. Barton, G. Thompson, J. Scott\",\"doi\":\"10.1016/j.atherosclerosissup.2019.08.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8592,\"journal\":{\"name\":\"Atherosclerosis. Supplements\",\"volume\":\"38 \",\"pages\":\"Pages e6-e7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.atherosclerosissup.2019.08.014\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Atherosclerosis. Supplements\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1567568819300376\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atherosclerosis. Supplements","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567568819300376","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}